Clinical Trial Update: Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating targeting pulmonary perfusion in alpha-1 antitrypsin deficiency with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Columbia University | Conditions: Alpha-1 Antitrypsin Deficiency, Emphysema | Phase 2 | Status: COMPLETED | Results posted: 2021-02-17